{
    "Trade/Device Name(s)": [
        "CAMPYLOBACTER CHEK",
        "CAMPYLOBACTER CHEK\u2122"
    ],
    "Submitter Information": "TECHLAB, Inc.",
    "510(k) Number": "K173219",
    "Predicate Device Reference 510(k) Number(s)": [
        "K083464"
    ],
    "Regulatory Class": "Class I",
    "Product Code(s)": [
        "LQP"
    ],
    "Summary Letter Date": "September 29, 2017",
    "Summary Letter Received Date": "October 25, 2017",
    "Submission Date": "January 22, 2018",
    "Regulation Number(s)": [
        "21 CFR 866.3110"
    ],
    "Regulation Name(s)": [
        "Campylobacter fetus serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Campylobacter-specific antigen",
        "C. jejuni",
        "C. coli"
    ],
    "Specimen Type(s)": [
        "Human fecal specimens"
    ],
    "Specimen Container(s)": [
        "Transport media (Cary Blair)",
        "C&S Transport Media",
        "Unpreserved"
    ],
    "Instrument(s)/Platform(s)": [],
    "Method(s)/Technology(ies)": [
        "Enzyme immunoassay (EIA)",
        "ELISA (enzyme-linked immunosorbent assay)"
    ],
    "Methodologies": [
        "Antigen detection",
        "Immunoassay"
    ],
    "Submission Type(s)": [
        "Test",
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for CAMPYLOBACTER CHEK enzyme immunoassay kit for qualitative detection of Campylobacter-specific antigens in human fecal specimens",
    "Indications for Use Summary": "Qualitative detection of Campylobacter-specific antigen (C. jejuni and C. coli) in human fecal specimens from patients with signs and symptoms of gastroenteritis, using preserved or unpreserved specimens",
    "fda_folder": "Microbiology"
}